SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-005965
Filing Date
2020-01-22
Accepted
2020-01-22 17:01:51
Documents
1
Period of Report
2020-01-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm205452-1_4.html 4  
1 OWNERSHIP DOCUMENT tm205452-1_4.xml 4 4136
  Complete submission text file 0001104659-20-005965.txt   5775
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 20539477